Sharepoint Solutions
PRODUCTS
-
AES Box™ is a modular architectural system that delivers our best-in-class modular cleanroom design and integrates seamlessly with your current project infrastructure while providing the compliance and quality you need.
-
Scale up your viral vector or gene therapy manufacturing cost-effectively with HEKima Adherent, a QuickStart Media designed to simplify customization and accelerate development and production.
-
Manufacture high-quality products with streamlined compliance.
-
The MM1A series is a versatile, robust, and broadband double-balanced mixer with an integrated broadband LO driver amplifier.
-
The MBX32CTR is a complete solution for mmWave and sub-THz OTA measurement with a quiet zone of 150mm that includes a full benchtop anechoic chamber, a 3D positioner, and a pair of STO-series frequency extenders.
WHITE PAPERS AND CASE STUDIES
-
The Impact Of Artificial Intelligence On CQV
AI is revolutionizing CQV in life sciences by automating documentation, enabling real-time monitoring, and driving predictive quality to boost efficiency and compliance across validation processes.
-
Designing More Representative Trials Through Strategic Planning
Strategic planning for representative clinical trials improves outcomes, regulatory alignment, recruitment efficiency, and commercial value by ensuring study populations mirror real-world patients.
-
Cell Line Development: The Linchpin In Biotherapeutic Development
Review key factors for building a reliable CLD strategy, and learn how the right CDMO can help you achieve the high quality, high yield, and speed needed to successfully bring a biologic to market.
-
Why Early Market Access Planning Is Crucial In CGT Commercial Strategy
Bringing cell and gene therapies (CGTs) to market and ensuring patient access is a complex process. Discover how developing a market access strategy and partnering with experts can help.
-
FDA Recommendations For Gene Therapy For PMDs
Explore insight into the strategies and FDA recommendations for executing gene therapy development programs, specifically for primary mitochondrial diseases (PMDs).
-
The Impact Of High Inflation And The Great Resignation On Clinical Site Budgeting
The twin pressures of inflation and attrition prolong negotiations between sponsors and clinical sites, stalling drug development. Sponsors need up-to-date, reliable benchmark data to negotiate fair market value budgets.
-
Navigating Digital Transformation For Pharmaceutical CDMOs
Discover how CDMOs can modernize operations, safeguard data integrity, and improve audit readiness with practical strategies for connecting systems and reducing validation burdens.
-
Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.
-
Enabling CDMOs To Focus On Core Priorities
Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
Innovative ASD Technology Improves Abandoned Cancer Medication
Review this case to learn how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.
-
Optimizing Generative AI In Clinical Operations
Crafting a thoughtful strategy to determine the optimal utilization of Generative AI in advancing medical research and enhancing patient well-being.
-
Hospital-Based eCOA Implementation: Real Challenges In Infectious Disease Trials
This resource outlines proven strategies to reduce delays, improve compliance, and meet regulatory standards for PRO data in infectious disease studies.
NEWS
-
Groundbreaking New Partnership For Global Test & Measurement Company Axiometrix Solutions In France3/27/2025
By today, Frank Mayer, CCO of Axiometrix Solutions and representatives of French distributor Equipements Scientifiques (ES), signed an agreement about a partnership between the two companies, representing a milestone for the expansions of the sales channel in the EMEA region.
-
H2APEX And Copenhagen Infrastructure Partners Enter Into Strategic Partnership For Pioneering Hydrogen Project In Lubmin8/5/2025
H2APEX Group SCA announces that Copenhagen Infrastructure Partners (CIP) – one of the world’s leading investment companies in energy infrastructure investments – has acquired a majority stake of 70% in the first phase of H2APEX’s IPCEI-funded hydrogen project in Lubmin through its Energy Transition Fund (CI ETF I) as a strategic investor.
-
Securing Water Systems Against Cyber-Threats: Idaho Leads With Cyber-Informed Engineering3/6/2025
When it comes to cybersecurity research, the Idaho National Laboratory (INL) and Idaho have a relationship that dates back to the 1990s and was hallmarked in 2019 with the opening of the state-funded Cybercore Integration Center on INL’s Research and Education Campus in Idaho Falls.
-
Comau Develops Innovative Industrial Collaborative Robotic Solutions As Part Of The CONVERGING Project11/26/2025
Comau is contributing to the European Union’s CONVERGING project, which aims to advance smart and reconfigurable production systems to meet the challenges of modern manufacturing.
-
EPA Announces $7 Billion In Newly Available WIFIA Funding And Five New WIFIA Loan Approvals11/20/2025
The U.S. Environmental Protection Agency (EPA) has announced $6.5 billion in Water Infrastructure Finance and Innovation Act (WIFIA) funding available for water systems, with an additional $550 million available to states. Interested entities can apply for this funding through a rolling application process.